Sawicki Mark W 4

What Happened Mark W. Sawicki, Chief Scientific Officer of Cryoport, sold 1,341 shares of Cryoport common stock in an open-market/private sale on March 23, 2026. The shares were sold at $8.18 per share for total proceeds of $10,969. The filing notes the sale was required to satisfy tax withholding obligations upon the vesting of restricted stock.

Key Details

• Transaction date: 2026-03-23
• Transaction type/code: Sale (S); footnote indicates sale to cover taxes on vested restricted stock (F1)
• Price per share: $8.18
• Shares sold: 1,341
• Total proceeds reported: $10,969
• Shares owned after transaction: Not specified in the provided filing
• Filing date: 2026-03-25 — filed two days after the transaction (appears timely under SEC reporting rules)

Context

• The filing’s footnote states the shares were sold to pay taxes due on vested restricted stock rights. Such withholding-related sales are routine and generally viewed as administrative rather than a signal of insider sentiment. Purchases or voluntary sales are typically more informative about an insider’s view of the company.